http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2025, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 25 Sep 2025 08:01:13 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Board+Changes/Lucid+Diagnostics+names+John+Palumbo+to+board+of+directors/25374971.html <p>Lucid Diagnostics Inc. (NASDAQ: LUCD) appointed John R. Palumbo to its board of directors, effective September 22, 2025, according to a company statement.</p> <p>Palumbo brings 40 years of healthcare executive experience spanning early-stage ventures, growth companies, and Fortune 100 enterprises. He has guided two companies through initial public offerings and led transformation initiatives at large organizations.</p> <p>Most recently, Palumbo served as executive chairman of ValueHealth, a value-based surgical platform, where he led a recapitalization in 2018 and a strategic investment in 2022. He previously held senior executive roles at AmerisourceBergen Corporation (NYSE: ABC), where he led the provider business unit and its http://www.streetinsider.com/Board+Changes/Lucid+Diagnostics+names+John+Palumbo+to+board+of+directors/25374971.html Thu, 25 Sep 2025 08:01:13 -0400 ABC LUCD MDRX O.26465211 O.52480795 PAVM http://www.streetinsider.com/Board+Changes/Lucid+Diagnostics+names+John+Palumbo+to+board+of+directors/25374971.html <p>Lucid Diagnostics Inc. (NASDAQ: LUCD) appointed John R. Palumbo to its board of directors, effective September 22, 2025, according to a company statement.</p> <p>Palumbo brings 40 years of healthcare executive experience spanning early-stage ventures, growth companies, and Fortune 100 enterprises. He has guided two companies through initial public offerings and led transformation initiatives at large organizations.</p> <p>Most recently, Palumbo served as executive chairman of ValueHealth, a value-based surgical platform, where he led a recapitalization in 2018 and a strategic investment in 2022. He previously held senior executive roles at AmerisourceBergen Corporation (NYSE: ABC), where he led the provider business unit and its http://www.streetinsider.com/Board+Changes/Lucid+Diagnostics+names+John+Palumbo+to+board+of+directors/25374971.html Thu, 25 Sep 2025 08:01:13 -0400 ABC LUCD MDRX O.26465211 O.52480795 PAVM http://www.streetinsider.com/Board+Changes/Lucid+Diagnostics+names+John+Palumbo+to+board+of+directors/25374971.html <p>Lucid Diagnostics Inc. (NASDAQ: LUCD) appointed John R. Palumbo to its board of directors, effective September 22, 2025, according to a company statement.</p> <p>Palumbo brings 40 years of healthcare executive experience spanning early-stage ventures, growth companies, and Fortune 100 enterprises. He has guided two companies through initial public offerings and led transformation initiatives at large organizations.</p> <p>Most recently, Palumbo served as executive chairman of ValueHealth, a value-based surgical platform, where he led a recapitalization in 2018 and a strategic investment in 2022. He previously held senior executive roles at AmerisourceBergen Corporation (NYSE: ABC), where he led the provider business unit and its http://www.streetinsider.com/Board+Changes/Lucid+Diagnostics+names+John+Palumbo+to+board+of+directors/25374971.html Thu, 25 Sep 2025 08:01:13 -0400 ABC LUCD MDRX O.26465211 O.52480795 PAVM http://www.streetinsider.com/Board+Changes/Lucid+Diagnostics+names+John+Palumbo+to+board+of+directors/25374971.html <p>Lucid Diagnostics Inc. (NASDAQ: LUCD) appointed John R. Palumbo to its board of directors, effective September 22, 2025, according to a company statement.</p> <p>Palumbo brings 40 years of healthcare executive experience spanning early-stage ventures, growth companies, and Fortune 100 enterprises. He has guided two companies through initial public offerings and led transformation initiatives at large organizations.</p> <p>Most recently, Palumbo served as executive chairman of ValueHealth, a value-based surgical platform, where he led a recapitalization in 2018 and a strategic investment in 2022. He previously held senior executive roles at AmerisourceBergen Corporation (NYSE: ABC), where he led the provider business unit and its http://www.streetinsider.com/Board+Changes/Lucid+Diagnostics+names+John+Palumbo+to+board+of+directors/25374971.html Thu, 25 Sep 2025 08:01:13 -0400 ABC LUCD MDRX O.26465211 O.52480795 PAVM http://www.streetinsider.com/Board+Changes/Lucid+Diagnostics+names+John+Palumbo+to+board+of+directors/25374971.html <p>Lucid Diagnostics Inc. (NASDAQ: LUCD) appointed John R. Palumbo to its board of directors, effective September 22, 2025, according to a company statement.</p> <p>Palumbo brings 40 years of healthcare executive experience spanning early-stage ventures, growth companies, and Fortune 100 enterprises. He has guided two companies through initial public offerings and led transformation initiatives at large organizations.</p> <p>Most recently, Palumbo served as executive chairman of ValueHealth, a value-based surgical platform, where he led a recapitalization in 2018 and a strategic investment in 2022. He previously held senior executive roles at AmerisourceBergen Corporation (NYSE: ABC), where he led the provider business unit and its http://www.streetinsider.com/Board+Changes/Lucid+Diagnostics+names+John+Palumbo+to+board+of+directors/25374971.html Thu, 25 Sep 2025 08:01:13 -0400 ABC LUCD MDRX O.26465211 O.52480795 PAVM http://www.streetinsider.com/Board+Changes/Lucid+Diagnostics+names+John+Palumbo+to+board+of+directors/25374971.html <p>Lucid Diagnostics Inc. (NASDAQ: LUCD) appointed John R. Palumbo to its board of directors, effective September 22, 2025, according to a company statement.</p> <p>Palumbo brings 40 years of healthcare executive experience spanning early-stage ventures, growth companies, and Fortune 100 enterprises. He has guided two companies through initial public offerings and led transformation initiatives at large organizations.</p> <p>Most recently, Palumbo served as executive chairman of ValueHealth, a value-based surgical platform, where he led a recapitalization in 2018 and a strategic investment in 2022. He previously held senior executive roles at AmerisourceBergen Corporation (NYSE: ABC), where he led the provider business unit and its http://www.streetinsider.com/Board+Changes/Lucid+Diagnostics+names+John+Palumbo+to+board+of+directors/25374971.html Thu, 25 Sep 2025 08:01:13 -0400 ABC LUCD MDRX O.26465211 O.52480795 PAVM http://www.streetinsider.com/Press+Releases/Lucid+Diagnostics+Appoints+Healthcare+Industry+Veteran+John+R.+Palumbo+to+Board+of+Directors/25374965.html <div class="xn-content"> <p class="prntac"><i>Growth-focused healthcare executive brings 40 years of executive leadership experience across multiple industry sectors</i></p> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Sept. 25, 2025</chron></span> /PRNewswire/ -- <b><u><a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4518401-1&amp;h=2648863139&amp;u=https%3A%2F%2Fwww.luciddx.com%2F&amp;a=Lucid+Diagnostics+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:LUCD" idsrc="xmltag.org" >Lucid Diagnostics Inc.</span></a></u> </b>(Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of <span value="NASDAQ-SMALL:PAVM" idsrc="xmltag.org" >PAVmed Inc.</span> (Nasdaq: PAVM), today announced the appointment of accomplished healthcare executive <person>John R. Palumbo</person> to its Board of Directors, effective <chron>September 22, 2025</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Lucid+Diagnostics+Appoints+Healthcare+Industry+Veteran+John+R.+Palumbo+to+Board+of+Directors/25374965.html Thu, 25 Sep 2025 08:01:00 -0400 ABC LUCD MDRX O.26465211 O.52480795 PAVM http://www.streetinsider.com/Press+Releases/Lucid+Diagnostics+Appoints+Healthcare+Industry+Veteran+John+R.+Palumbo+to+Board+of+Directors/25374965.html <div class="xn-content"> <p class="prntac"><i>Growth-focused healthcare executive brings 40 years of executive leadership experience across multiple industry sectors</i></p> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Sept. 25, 2025</chron></span> /PRNewswire/ -- <b><u><a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4518401-1&amp;h=2648863139&amp;u=https%3A%2F%2Fwww.luciddx.com%2F&amp;a=Lucid+Diagnostics+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:LUCD" idsrc="xmltag.org" >Lucid Diagnostics Inc.</span></a></u> </b>(Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of <span value="NASDAQ-SMALL:PAVM" idsrc="xmltag.org" >PAVmed Inc.</span> (Nasdaq: PAVM), today announced the appointment of accomplished healthcare executive <person>John R. Palumbo</person> to its Board of Directors, effective <chron>September 22, 2025</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Lucid+Diagnostics+Appoints+Healthcare+Industry+Veteran+John+R.+Palumbo+to+Board+of+Directors/25374965.html Thu, 25 Sep 2025 08:01:00 -0400 ABC LUCD MDRX O.26465211 O.52480795 PAVM http://www.streetinsider.com/Press+Releases/Lucid+Diagnostics+Appoints+Healthcare+Industry+Veteran+John+R.+Palumbo+to+Board+of+Directors/25374965.html <div class="xn-content"> <p class="prntac"><i>Growth-focused healthcare executive brings 40 years of executive leadership experience across multiple industry sectors</i></p> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Sept. 25, 2025</chron></span> /PRNewswire/ -- <b><u><a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4518401-1&amp;h=2648863139&amp;u=https%3A%2F%2Fwww.luciddx.com%2F&amp;a=Lucid+Diagnostics+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:LUCD" idsrc="xmltag.org" >Lucid Diagnostics Inc.</span></a></u> </b>(Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of <span value="NASDAQ-SMALL:PAVM" idsrc="xmltag.org" >PAVmed Inc.</span> (Nasdaq: PAVM), today announced the appointment of accomplished healthcare executive <person>John R. Palumbo</person> to its Board of Directors, effective <chron>September 22, 2025</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Lucid+Diagnostics+Appoints+Healthcare+Industry+Veteran+John+R.+Palumbo+to+Board+of+Directors/25374965.html Thu, 25 Sep 2025 08:01:00 -0400 ABC LUCD MDRX O.26465211 O.52480795 PAVM http://www.streetinsider.com/Press+Releases/Lucid+Diagnostics+Appoints+Healthcare+Industry+Veteran+John+R.+Palumbo+to+Board+of+Directors/25374965.html <div class="xn-content"> <p class="prntac"><i>Growth-focused healthcare executive brings 40 years of executive leadership experience across multiple industry sectors</i></p> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Sept. 25, 2025</chron></span> /PRNewswire/ -- <b><u><a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4518401-1&amp;h=2648863139&amp;u=https%3A%2F%2Fwww.luciddx.com%2F&amp;a=Lucid+Diagnostics+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:LUCD" idsrc="xmltag.org" >Lucid Diagnostics Inc.</span></a></u> </b>(Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of <span value="NASDAQ-SMALL:PAVM" idsrc="xmltag.org" >PAVmed Inc.</span> (Nasdaq: PAVM), today announced the appointment of accomplished healthcare executive <person>John R. Palumbo</person> to its Board of Directors, effective <chron>September 22, 2025</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Lucid+Diagnostics+Appoints+Healthcare+Industry+Veteran+John+R.+Palumbo+to+Board+of+Directors/25374965.html Thu, 25 Sep 2025 08:01:00 -0400 ABC LUCD MDRX O.26465211 O.52480795 PAVM http://www.streetinsider.com/Press+Releases/Lucid+Diagnostics+Appoints+Healthcare+Industry+Veteran+John+R.+Palumbo+to+Board+of+Directors/25374965.html <div class="xn-content"> <p class="prntac"><i>Growth-focused healthcare executive brings 40 years of executive leadership experience across multiple industry sectors</i></p> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Sept. 25, 2025</chron></span> /PRNewswire/ -- <b><u><a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4518401-1&amp;h=2648863139&amp;u=https%3A%2F%2Fwww.luciddx.com%2F&amp;a=Lucid+Diagnostics+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:LUCD" idsrc="xmltag.org" >Lucid Diagnostics Inc.</span></a></u> </b>(Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of <span value="NASDAQ-SMALL:PAVM" idsrc="xmltag.org" >PAVmed Inc.</span> (Nasdaq: PAVM), today announced the appointment of accomplished healthcare executive <person>John R. Palumbo</person> to its Board of Directors, effective <chron>September 22, 2025</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Lucid+Diagnostics+Appoints+Healthcare+Industry+Veteran+John+R.+Palumbo+to+Board+of+Directors/25374965.html Thu, 25 Sep 2025 08:01:00 -0400 ABC LUCD MDRX O.26465211 O.52480795 PAVM http://www.streetinsider.com/Press+Releases/Lucid+Diagnostics+Appoints+Healthcare+Industry+Veteran+John+R.+Palumbo+to+Board+of+Directors/25374965.html <div class="xn-content"> <p class="prntac"><i>Growth-focused healthcare executive brings 40 years of executive leadership experience across multiple industry sectors</i></p> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Sept. 25, 2025</chron></span> /PRNewswire/ -- <b><u><a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4518401-1&amp;h=2648863139&amp;u=https%3A%2F%2Fwww.luciddx.com%2F&amp;a=Lucid+Diagnostics+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:LUCD" idsrc="xmltag.org" >Lucid Diagnostics Inc.</span></a></u> </b>(Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of <span value="NASDAQ-SMALL:PAVM" idsrc="xmltag.org" >PAVmed Inc.</span> (Nasdaq: PAVM), today announced the appointment of accomplished healthcare executive <person>John R. Palumbo</person> to its Board of Directors, effective <chron>September 22, 2025</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Lucid+Diagnostics+Appoints+Healthcare+Industry+Veteran+John+R.+Palumbo+to+Board+of+Directors/25374965.html Thu, 25 Sep 2025 08:01:00 -0400 ABC LUCD MDRX O.26465211 O.52480795 PAVM http://www.streetinsider.com/PRNewswire/Lucid+Diagnostics+Appoints+Healthcare+Industry+Veteran+John+R.+Palumbo+to+Board+of+Directors/25374965.html <div class="xn-content"> <p class="prntac"><i>Growth-focused healthcare executive brings 40 years of executive leadership experience across multiple industry sectors</i></p> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Sept. 25, 2025</chron></span> /PRNewswire/ -- <b><u><a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4518401-1&amp;h=2648863139&amp;u=https%3A%2F%2Fwww.luciddx.com%2F&amp;a=Lucid+Diagnostics+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:LUCD" idsrc="xmltag.org" >Lucid Diagnostics Inc.</span></a></u> </b>(Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of <span value="NASDAQ-SMALL:PAVM" idsrc="xmltag.org" >PAVmed Inc.</span> (Nasdaq: PAVM), today announced the appointment of accomplished healthcare executive <person>John R. Palumbo</person> to its Board of Directors, effective <chron>September 22, 2025</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Lucid+Diagnostics+Appoints+Healthcare+Industry+Veteran+John+R.+Palumbo+to+Board+of+Directors/25374965.html Thu, 25 Sep 2025 08:01:00 -0400 ABC LUCD MDRX O.26465211 O.52480795 PAVM http://www.streetinsider.com/PRNewswire/Lucid+Diagnostics+Appoints+Healthcare+Industry+Veteran+John+R.+Palumbo+to+Board+of+Directors/25374965.html <div class="xn-content"> <p class="prntac"><i>Growth-focused healthcare executive brings 40 years of executive leadership experience across multiple industry sectors</i></p> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Sept. 25, 2025</chron></span> /PRNewswire/ -- <b><u><a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4518401-1&amp;h=2648863139&amp;u=https%3A%2F%2Fwww.luciddx.com%2F&amp;a=Lucid+Diagnostics+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:LUCD" idsrc="xmltag.org" >Lucid Diagnostics Inc.</span></a></u> </b>(Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of <span value="NASDAQ-SMALL:PAVM" idsrc="xmltag.org" >PAVmed Inc.</span> (Nasdaq: PAVM), today announced the appointment of accomplished healthcare executive <person>John R. Palumbo</person> to its Board of Directors, effective <chron>September 22, 2025</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Lucid+Diagnostics+Appoints+Healthcare+Industry+Veteran+John+R.+Palumbo+to+Board+of+Directors/25374965.html Thu, 25 Sep 2025 08:01:00 -0400 ABC LUCD MDRX O.26465211 O.52480795 PAVM http://www.streetinsider.com/PRNewswire/Lucid+Diagnostics+Appoints+Healthcare+Industry+Veteran+John+R.+Palumbo+to+Board+of+Directors/25374965.html <div class="xn-content"> <p class="prntac"><i>Growth-focused healthcare executive brings 40 years of executive leadership experience across multiple industry sectors</i></p> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Sept. 25, 2025</chron></span> /PRNewswire/ -- <b><u><a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4518401-1&amp;h=2648863139&amp;u=https%3A%2F%2Fwww.luciddx.com%2F&amp;a=Lucid+Diagnostics+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:LUCD" idsrc="xmltag.org" >Lucid Diagnostics Inc.</span></a></u> </b>(Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of <span value="NASDAQ-SMALL:PAVM" idsrc="xmltag.org" >PAVmed Inc.</span> (Nasdaq: PAVM), today announced the appointment of accomplished healthcare executive <person>John R. Palumbo</person> to its Board of Directors, effective <chron>September 22, 2025</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Lucid+Diagnostics+Appoints+Healthcare+Industry+Veteran+John+R.+Palumbo+to+Board+of+Directors/25374965.html Thu, 25 Sep 2025 08:01:00 -0400 ABC LUCD MDRX O.26465211 O.52480795 PAVM http://www.streetinsider.com/PRNewswire/Lucid+Diagnostics+Appoints+Healthcare+Industry+Veteran+John+R.+Palumbo+to+Board+of+Directors/25374965.html <div class="xn-content"> <p class="prntac"><i>Growth-focused healthcare executive brings 40 years of executive leadership experience across multiple industry sectors</i></p> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Sept. 25, 2025</chron></span> /PRNewswire/ -- <b><u><a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4518401-1&amp;h=2648863139&amp;u=https%3A%2F%2Fwww.luciddx.com%2F&amp;a=Lucid+Diagnostics+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:LUCD" idsrc="xmltag.org" >Lucid Diagnostics Inc.</span></a></u> </b>(Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of <span value="NASDAQ-SMALL:PAVM" idsrc="xmltag.org" >PAVmed Inc.</span> (Nasdaq: PAVM), today announced the appointment of accomplished healthcare executive <person>John R. Palumbo</person> to its Board of Directors, effective <chron>September 22, 2025</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Lucid+Diagnostics+Appoints+Healthcare+Industry+Veteran+John+R.+Palumbo+to+Board+of+Directors/25374965.html Thu, 25 Sep 2025 08:01:00 -0400 ABC LUCD MDRX O.26465211 O.52480795 PAVM http://www.streetinsider.com/PRNewswire/Lucid+Diagnostics+Appoints+Healthcare+Industry+Veteran+John+R.+Palumbo+to+Board+of+Directors/25374965.html <div class="xn-content"> <p class="prntac"><i>Growth-focused healthcare executive brings 40 years of executive leadership experience across multiple industry sectors</i></p> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Sept. 25, 2025</chron></span> /PRNewswire/ -- <b><u><a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4518401-1&amp;h=2648863139&amp;u=https%3A%2F%2Fwww.luciddx.com%2F&amp;a=Lucid+Diagnostics+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:LUCD" idsrc="xmltag.org" >Lucid Diagnostics Inc.</span></a></u> </b>(Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of <span value="NASDAQ-SMALL:PAVM" idsrc="xmltag.org" >PAVmed Inc.</span> (Nasdaq: PAVM), today announced the appointment of accomplished healthcare executive <person>John R. Palumbo</person> to its Board of Directors, effective <chron>September 22, 2025</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Lucid+Diagnostics+Appoints+Healthcare+Industry+Veteran+John+R.+Palumbo+to+Board+of+Directors/25374965.html Thu, 25 Sep 2025 08:01:00 -0400 ABC LUCD MDRX O.26465211 O.52480795 PAVM http://www.streetinsider.com/PRNewswire/Lucid+Diagnostics+Appoints+Healthcare+Industry+Veteran+John+R.+Palumbo+to+Board+of+Directors/25374965.html <div class="xn-content"> <p class="prntac"><i>Growth-focused healthcare executive brings 40 years of executive leadership experience across multiple industry sectors</i></p> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Sept. 25, 2025</chron></span> /PRNewswire/ -- <b><u><a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4518401-1&amp;h=2648863139&amp;u=https%3A%2F%2Fwww.luciddx.com%2F&amp;a=Lucid+Diagnostics+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:LUCD" idsrc="xmltag.org" >Lucid Diagnostics Inc.</span></a></u> </b>(Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of <span value="NASDAQ-SMALL:PAVM" idsrc="xmltag.org" >PAVmed Inc.</span> (Nasdaq: PAVM), today announced the appointment of accomplished healthcare executive <person>John R. Palumbo</person> to its Board of Directors, effective <chron>September 22, 2025</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Lucid+Diagnostics+Appoints+Healthcare+Industry+Veteran+John+R.+Palumbo+to+Board+of+Directors/25374965.html Thu, 25 Sep 2025 08:01:00 -0400 ABC LUCD MDRX O.26465211 O.52480795 PAVM http://www.streetinsider.com/Press+Releases/Cencora%2C+Formerly+AmerisourceBergen%2C+Announces+Date+and+Time+for+Fourth+Quarter+Fiscal+2023+Earnings+Release/22226643.html <p> CONSHOHOCKEN, Pa.--(BUSINESS WIRE)-- Cencora, Inc. (NYSE: COR), formerly AmerisourceBergen Corporation, today announced that it plans to release its results for the Fourth Quarter of Fiscal 2023 on Thursday, November 2, 2023, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on November 2, 2023. </p><p> Participating in the conference call will be: <br />Steven H. Collis, Chairman, President &amp; Chief Executive Officer <br />James F. Cleary, Executive Vice President &amp; Chief Financial Officer </p><p> The live call will be webcast via the Company’s website at http://www.streetinsider.com/Press+Releases/Cencora%2C+Formerly+AmerisourceBergen%2C+Announces+Date+and+Time+for+Fourth+Quarter+Fiscal+2023+Earnings+Release/22226643.html Mon, 02 Oct 2023 16:30:00 -0400 ABC COR O.00026816 http://www.streetinsider.com/Press+Releases/Cencora%2C+Formerly+AmerisourceBergen%2C+Announces+Date+and+Time+for+Fourth+Quarter+Fiscal+2023+Earnings+Release/22226643.html <p> CONSHOHOCKEN, Pa.--(BUSINESS WIRE)-- Cencora, Inc. (NYSE: COR), formerly AmerisourceBergen Corporation, today announced that it plans to release its results for the Fourth Quarter of Fiscal 2023 on Thursday, November 2, 2023, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on November 2, 2023. </p><p> Participating in the conference call will be: <br />Steven H. Collis, Chairman, President &amp; Chief Executive Officer <br />James F. Cleary, Executive Vice President &amp; Chief Financial Officer </p><p> The live call will be webcast via the Company’s website at http://www.streetinsider.com/Press+Releases/Cencora%2C+Formerly+AmerisourceBergen%2C+Announces+Date+and+Time+for+Fourth+Quarter+Fiscal+2023+Earnings+Release/22226643.html Mon, 02 Oct 2023 16:30:00 -0400 ABC COR O.00026816 http://www.streetinsider.com/Press+Releases/Cencora%2C+Formerly+AmerisourceBergen%2C+Announces+Date+and+Time+for+Fourth+Quarter+Fiscal+2023+Earnings+Release/22226643.html <p> CONSHOHOCKEN, Pa.--(BUSINESS WIRE)-- Cencora, Inc. (NYSE: COR), formerly AmerisourceBergen Corporation, today announced that it plans to release its results for the Fourth Quarter of Fiscal 2023 on Thursday, November 2, 2023, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on November 2, 2023. </p><p> Participating in the conference call will be: <br />Steven H. Collis, Chairman, President &amp; Chief Executive Officer <br />James F. Cleary, Executive Vice President &amp; Chief Financial Officer </p><p> The live call will be webcast via the Company’s website at http://www.streetinsider.com/Press+Releases/Cencora%2C+Formerly+AmerisourceBergen%2C+Announces+Date+and+Time+for+Fourth+Quarter+Fiscal+2023+Earnings+Release/22226643.html Mon, 02 Oct 2023 16:30:00 -0400 ABC COR O.00026816 http://www.streetinsider.com/Business+Wire/Cencora%2C+Formerly+AmerisourceBergen%2C+Announces+Date+and+Time+for+Fourth+Quarter+Fiscal+2023+Earnings+Release/22226643.html <p> CONSHOHOCKEN, Pa.--(BUSINESS WIRE)-- Cencora, Inc. (NYSE: COR), formerly AmerisourceBergen Corporation, today announced that it plans to release its results for the Fourth Quarter of Fiscal 2023 on Thursday, November 2, 2023, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on November 2, 2023. </p><p> Participating in the conference call will be: <br />Steven H. Collis, Chairman, President &amp; Chief Executive Officer <br />James F. Cleary, Executive Vice President &amp; Chief Financial Officer </p><p> The live call will be webcast via the Company’s website at http://www.streetinsider.com/Business+Wire/Cencora%2C+Formerly+AmerisourceBergen%2C+Announces+Date+and+Time+for+Fourth+Quarter+Fiscal+2023+Earnings+Release/22226643.html Mon, 02 Oct 2023 16:30:00 -0400 ABC COR O.00026816 http://www.streetinsider.com/Business+Wire/Cencora%2C+Formerly+AmerisourceBergen%2C+Announces+Date+and+Time+for+Fourth+Quarter+Fiscal+2023+Earnings+Release/22226643.html <p> CONSHOHOCKEN, Pa.--(BUSINESS WIRE)-- Cencora, Inc. (NYSE: COR), formerly AmerisourceBergen Corporation, today announced that it plans to release its results for the Fourth Quarter of Fiscal 2023 on Thursday, November 2, 2023, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on November 2, 2023. </p><p> Participating in the conference call will be: <br />Steven H. Collis, Chairman, President &amp; Chief Executive Officer <br />James F. Cleary, Executive Vice President &amp; Chief Financial Officer </p><p> The live call will be webcast via the Company’s website at http://www.streetinsider.com/Business+Wire/Cencora%2C+Formerly+AmerisourceBergen%2C+Announces+Date+and+Time+for+Fourth+Quarter+Fiscal+2023+Earnings+Release/22226643.html Mon, 02 Oct 2023 16:30:00 -0400 ABC COR O.00026816 http://www.streetinsider.com/Business+Wire/Cencora%2C+Formerly+AmerisourceBergen%2C+Announces+Date+and+Time+for+Fourth+Quarter+Fiscal+2023+Earnings+Release/22226643.html <p> CONSHOHOCKEN, Pa.--(BUSINESS WIRE)-- Cencora, Inc. (NYSE: COR), formerly AmerisourceBergen Corporation, today announced that it plans to release its results for the Fourth Quarter of Fiscal 2023 on Thursday, November 2, 2023, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on November 2, 2023. </p><p> Participating in the conference call will be: <br />Steven H. Collis, Chairman, President &amp; Chief Executive Officer <br />James F. Cleary, Executive Vice President &amp; Chief Financial Officer </p><p> The live call will be webcast via the Company’s website at http://www.streetinsider.com/Business+Wire/Cencora%2C+Formerly+AmerisourceBergen%2C+Announces+Date+and+Time+for+Fourth+Quarter+Fiscal+2023+Earnings+Release/22226643.html Mon, 02 Oct 2023 16:30:00 -0400 ABC COR O.00026816 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cencora%2C+Inc.+++++++++++++For%3A+Sep+25++Filed+by%3A+Mauch+Robert+P./22207555.html si-local-file:///var/storage/secattach/20230927/22207555.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cencora%2C+Inc.+++++++++++++For%3A+Sep+25++Filed+by%3A+Mauch+Robert+P./22207555.html Wed, 27 Sep 2023 16:09:00 -0400 ABC COR O.00026816